Sinopharm Group Co., Ltd.
http://www.sinopharmholding.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sinopharm Group Co., Ltd.
Vaccine Star's Surprise Downfall Indicative Of Trouble In China’s COVID Push?
Apparently months after his actual detention, news has finally surfaced that a key researcher behind China's rapid development of a homegrown COVID-19 vaccine is said to have "severely violated" Communist Party rules and regulations and is the subject of a probe for possible corruption.
Vaccine Star's Surprise Downfall Indicative Of Trouble In China’s COVID Push?
Apparently months after his actual detention, news has finally surfaced that a key researcher behind China's rapid development of a homegrown COVID-19 vaccine is said to have "severely violated" Communist Party rules and regulations and is the subject of a probe for possible corruption.
New Front-Runner Emerges In China mRNA Booster Race
China's CSPC Pharmaceutical Group surprises by announcing investigator-initiated trial results for SYS6006, its mRNA COVID-19 vaccine candidate against the Omicron variant.
Wuhan Back In Spotlight As Delta Variant Highlights Booster Shots Urgency
Amid surging infections in several cities including Wuhan, China is urging vaccination among unvaccinated people, but a booster shot may be needed soon to address a low efficacy among Chinese vaccines, some say.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice